Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patient with chronic myeloid leukemia in complete cytogenetic response: what does it mean, and what does one do next?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Feb 2014

Marin David

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arterial Occlusive Diseases
Share to Bone Marrow Examination
Share to Cytogenetic Analysis
Share to Drug Substitution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fusion Proteins, bcr-abl

Share to Imatinib Mesylate

Share to Leukocyte Count

Share to Philadelphia Chromosome

Source

Identifiers

PMID: 24419129
DOI: 10.1200/JCO.2013.52.9230

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patient with chronic myeloid leukemia in complete cytogenetic response: what does it mean, and what does one do next?PMID 24419129Read ↗

Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upSemantic proximity Read ↗

[Treatment strategies for chronic myeloid leukemia].Semantic proximity Read ↗

Response definitions and European Leukemianet Management recommendations.Semantic proximity Read ↗

Case with chronic myeloid leukemia and T315I mutation, but still in complete molecular response under high dose imatinib therapy.Semantic proximity Read ↗

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WPSemantic proximity Read ↗

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)Semantic proximity Read ↗

Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid informationSemantic proximity Read ↗

[The influence of additive clonal chromosome abnormalities in Ph negative cells on the efficacy of chronic myeloid leukemia].Semantic proximity Read ↗

Practical considerations for monitoring patients with chronic myeloid leukemia.Semantic proximity Read ↗

Marked discordance between cytogenetic/molecular and morphologic findings in a patient with chronic myeloid leukemia.Semantic proximity Read ↗

Cytogenetic and molecular responses and outcome in chronic myelogenous leukemiaSemantic proximity Read ↗

What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.